EPISODE · Jan 13, 2025 · 29 MIN

Panic Opportunities

from Rebel's Edge with Jon & Pete Najarian

Jon and Pete dig into suspicious spec buying of Intra-Cellular Therapies prior to Johnson & Johnson's acquisition announcement, Sage Therapeutics fielding a buyout offer, Moderna slumping on reduced COVID vaccine demand, and Abercrombie failing to impress investors. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Episode metadata supplied by the publisher feed · Published Jan 13, 2025

Embed this episode

Attribution link and audio player

Ready to play

Panic Opportunities

0:00 29:38

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of Rebel's Edge with Jon & Pete Najarian?

This episode is 29 minutes long.

When was this Rebel's Edge with Jon & Pete Najarian episode published?

This episode was published on January 13, 2025.

Can I download this Rebel's Edge with Jon & Pete Najarian episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!